Yogurt in Nutrition Initiative Welcomes the Expertise of the International Osteoporosis Foundation as It Highlights the Role of Dairy Products on Bone Health

Uncategorized March 27, 2014 at 11:44 AM 0 comments

The importance of dairy products, including yogurt, to bone health has been recognised again today with the announcement of a new collaboration between the International Osteoporosis Foundation (IOF) and the Yogurt in Nutrition Initiative (YINI). IOF will join forces with the YINI and its current partner, the American Society forRead More

Norgine and Innovacell Dose First Patient in Phase IIb Clinical Trial of ICEF15, a Personalised Cell Therapy to Treat Faecal Incontinence

Uncategorized March 27, 2014 at 11:43 AM 0 comments

Norgine B.V. (“Norgine”) and Innovacell today announced that the first patient has been dosed in the Phase IIb STEFFI study, which has been designed to evaluate the clinical efficacy and safety of ICEF15 (autologous skeletal muscle derived cells), versus placebo in patients suffering from faecal incontinence. The STEFFI study willRead More

‘Early Access’ Scheme Unveiled for Innovative Medicines

‘Early Access’ Scheme Unveiled for Innovative Medicines

Uncategorized March 14, 2014 at 11:34 AM 0 comments

People with advanced cancer and other serious illnesses like dementia could soon benefit from early access to innovative and promising treatments. The Early Access to Medicines scheme would enable safe and promising drugs to be “fast tracked” into the NHS before they have even been granted a licence for use. TheRead More

NICE Consults on Draft Guidance Recommending New Drug for Type 2 Diabetes

Uncategorized February 21, 2014 at 4:53 PM 0 comments

NICE, the health and social care guidance body, is currently appraising canagliflozin (Invokana, Janssen-Cilag) when used in combination with other anti-diabetic drugs, including insulin, for the treatment of type 2 diabetes. In draft guidance issued today for consultation NICE has recommended canagliflozin as a treatment option for some people with the conditioni.Read More

Cancer Scan Avoids Exposing Younger Patients to Radiation

Uncategorized February 20, 2014 at 4:49 PM 0 comments

A new method of scanning young cancer patients for tumours has been developed that avoids exposing them to potentially harmful radiation, US researchers say. A team from the Stanford University School of Medicine has developed a new way of usingmagnetic resonance imaging (MRI) to look for cancer in children and youngRead More

The Musical Brain: Novel Study of Jazz Players Shows Common Brain Circuitry Processes Both Music and Language

Uncategorized February 19, 2014 at 4:40 PM 0 comments

Researchers scanned brains while musicians “traded fours The brains of jazz musicians engrossed in spontaneous, improvisational musical conversation showed robust activation of brain areas traditionally associated with spoken language and syntax, which are used to interpret the structure of phrases and sentences. But this musical conversation shut down brain areasRead More

Luxembourg National Health Fund Approves Reimbursement of XIFAXAN® 550

Uncategorized February 14, 2014 at 2:05 PM 0 comments

London, 14 February 2014. 13:00 GMT: Norgine today announced that Luxembourg’s National Health Fund, the Caisse Nationale de Santé (CNS), has approved the reimbursement of XIFAXAN® 550 (rifaximin-α 550mg) for the prevention of the recurrence of hepatic encephalopathy (HE) in accordance with its officially-approved summary of product characteristics. Hepatic encephalopathy is a potentially life-threatening neuropsychiatricRead More

IMBRUVICA™ (Ibrutinib) Now Approved in the u.s. For Patients with Chronic Lymphocytic Leukemia Who Have Received at Least One Prior Therapy

Uncategorized February 12, 2014 at 1:58 PM 0 comments

HORSHAM, PA, February 12, 2014 – Janssen Biotech, Inc. [“Janssen”] today announced the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA™ (ibrutinib) capsules for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.[1] IMBRUVICA was first approved in November 2013 for the treatmentRead More

Cancer Research UK Launches ‘Spaceship’ Smartphone Game to Seek Cancer Cures

Cancer Research UK Launches ‘Spaceship’ Smartphone Game to Seek Cancer Cures

Uncategorized February 4, 2014 at 1:51 PM 0 comments

Cancer Research UK today unveils Play to Cure: Genes in Space – a world-first mobile phone game in which people across the globe will be able to help scientists unravel gene data to find the answers to some of cancer’s toughest questions. “Play to Cure: Genes in Space will help us findRead More